Malaysia’s Big Caring Plans $750 Million IPO, Testing Appetite for Emerging Market Pharma
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.
Apotex Health's IPO on the TSX signals a thaw in Canadian public markets, potentially reviving equity issuance and investor sentiment.
Apotex's Toronto IPO filing advances the Canadian drugmaker's public listing, potentially boosting the TSX and healthcare sector sentiment.
Astellas Pharma shares fell in Tokyo after the company’s five-year strategic plan disappointed investors with modest growth targets and pipeline uncertainty.
Denmark's GDP outlook upgrade driven by pharmaceutical exports underscores the economic influence of Novo Nordisk's Ozempic and Wegovy, lifting growth expectations and…